Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Asahi Intecc (7747 JP): Strong FY25 Result; FY26 Guidance Initiation; New Business Plan Announced

Asahi Intecc (7747 JP): Strong Demand Drives H1FY26 Performance and FY26 Guidance Raise

Asahi Intecc (7747 JP): Well-Positioned to Meet FY Guidance; Long-Term Growth Levers Intact

Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/asahi-intecc-co-ltd" target="_blank" data-smartkarma-citation="entities:15915:1" rel="noopener">Asahi Intecc (7747 JP)</a> reported solid result for FY26, with all key parameters beating guidance. Strong overseas demand and favorable exchange rate fluctuation (yen depreciation) drove the performance.</li>
<li>Asahi Intecc expects both medical and device divisions to grow supported by expanding demands centered in overseas market. For FY27, the company guided for double-digit growth for all key parameters.</li>
<li>Asahi Intecc has revised upward the numerical targets for the final fiscal year (FY30) of its medium-term management plan, due to steady market improvement and favorable Fx.</li>
</ul>



Asahi Intecc (7747 JP) reported solid result for FY26, with all key parameters beating guidance. Strong overseas demand and favorable exchange rate fluctuation (yen depreciation) drove the performance.
Asahi Intecc expects both medical and device divisions to grow supported by expanding demands centered in overseas market. For FY27, the company guided for double-digit growth for all key parameters.
Asahi Intecc has revised upward the numerical targets for the final fiscal year (FY30) of its medium-term management plan, due to steady market improvement and favorable Fx.


Asahi Intecc (7747 JP): FY26 Ends on Strong Note; FY27 Guidance Initiation; MTM Plan Revised Upward